Kraig Biocraft Laboratories Announces Production Expansion
Kraig Biocraft Laboratories (OTCQB: KBLB) announced plans to add a third recombinant spider silk rearing center as part of a rapid production expansion. The company said it has opened two centers over the past 18 months and is identifying a site for the third facility, expecting to finalize a location within 60 days from the Oct. 6, 2025 announcement. The new center will be located in a leading silk‑production region to leverage local sericulture expertise, and the multi‑facility strategy is intended to enable continuous production and operational redundancy.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha annunciato piani per aggiungere un terzo centro di allevamento di seta di ragno ricombinante nell'ambito di una rapida espansione della produzione. L'azienda ha detto di aver aperto due centri negli ultimi 18 mesi e di identificare una sede per il terzo impianto, prevedendo di finalizzare la località entro 60 giorni a partire dall'annuncio del 6 ottobre 2025. Il nuovo centro sarà ubicato in una regione leader nella produzione della seta per sfruttare l'esperienza locale nella sericoltura, e la strategia multi-centro è finalizzata a garantire produzione continua e ridondanza operativa.
Kraig Biocraft Laboratories (OTCQB: KBLB) anunció planes para añadir un tercer centro de cría de seda de araña recombinante como parte de una rápida expansión de la producción. La empresa dijo haber abierto dos centros en los últimos 18 meses y está identificando un sitio para la tercera instalación, con la expectativa de finalizar una ubicación dentro de 60 días desde el anuncio del 6 de octubre de 2025. El nuevo centro estará ubicado en una región líder de producción de seda para aprovechar la experiencia local en sericultura, y la estrategia de múltiples centros pretende permitir una producción continua y redundancia operativa.
Kraig Biocraft Laboratories (OTCQB: KBLB) 는 빠른 생산 확대의 일환으로 세 번째 재조합 거미줄 실크 양식 센터를 추가할 계획을 발표했다. 회사는 지난 18개월 동안 두 개의 센터를 열었다고 말했고 세 번째 시설의 위치를 찾고 있으며 2025년 10월 6일 발표에서 60일 이내에 위치를 확정할 것으로 예상한다. 새 센터는 현지 양잠 전문 지식을 활용하기 위해 섬유 생산의 선두 지역에 위치할 것이며 다중 시설 전략은 연속적인 생산과 운용 중복성을 가능하게 하려는 것이다.
Kraig Biocraft Laboratories (OTCQB : KBLB) a annoncé des plans pour ajouter un troisième centre d'élevage de soie d'araignée recombinant dans le cadre d'une expansion rapide de la production. La société a déclaré avoir ouvert deux centres au cours des 18 derniers mois et qu'elle identifie un site pour la troisième installation, en prévoyant de finaliser l'emplacement dans 60 jours à partir de l'annonce du 6 octobre 2025. Le nouveau centre sera situé dans une région leader de la production de soie afin de tirer parti de l'expertise locale en sériculture, et la stratégie multi-centres vise à permettre une production continue et une redondance opérationnelle.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat Pläne angekündigt, ein drittes rekombinantes Spinnen-Seide-Zuchtzentrum im Rahmen einer raschen Produktionserweiterung hinzuzufügen. Das Unternehmen sagte, in den letzten 18 Monaten zwei Zentren eröffnet zu haben und identifiziert einen Standort für die dritte Einrichtung, wobei erwartet wird, den Standort innerhalb von 60 Tagen ab der Ankündigung vom 6. Oktober 2025 festzulegen. Das neue Zentrum wird in einer führenden Seidenproduktionsregion liegen, um die lokale Serikultur-Expertise zu nutzen, und die Mehrfachzentrumsstrategie soll eine kontinuierliche Produktion und operative Redundanz ermöglichen.
Kraig Biocraft Laboratories (OTCQB: KBLB) أعلنت خططاً لإضافة مركز ثالث لتربية حرير العناكب المُعاد تركيبه كجزء من توسيع الإنتاج بسرعة. قالت الشركة إنها افتتحت مركزين خلال الـ18 شهراً الماضية وتقوم بتحديد موقع للمرفق الثالث، مع توقع إنهاء اختيار المكان خلال 60 يوماً من إعلان 6 أكتوبر 2025. سيكون المركز الجديد في منطقة رائدة لإنتاج الحرير للاستفادة من خبرة التوالج المحلي، وتُراد منه استراتيجية تعدد المراكز تمكين الإنتاج المستمر والاحتياطي التشغيلي.
Kraig Biocraft Laboratories (OTCQB: KBLB) 宣布计划在快速扩大产能的过程中新增一个第三个重组蜘蛛丝养殖中心。公司表示在过去18个月里已开设两个中心，正在为第三个设施确定地点，预计将在2025年10月6日公告之日起的60天内确定位置。新中心将位于领先的丝绸生产地区，以利用当地养蚕专业知识，多中心战略旨在实现持续生产和运营冗余。
- Third rearing center planned; site selection to be finalized within 60 days
- Multi‑facility strategy aims to enable continuous production and redundancy
- New facility to be located in an established silk‑production region leveraging local expertise
- None.
ANN ARBOR, Mich., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is preparing to add a third production facility as part of its plans for rapid expansion of recombinant spider silk production.
Over the past 18 months, Kraig Labs has significantly advanced its production model, opening two rearing centers for recombinant spider silk production. The Company is now opening a third center to expand its capacity further.
The Company reports that it is now well underway in identifying a site for this new facility and anticipates finalizing a location within the next 60 days.
This new facility, like the Company's existing operations, will be established in one of the world's leading silk production regions. By situating operations within established silk-growing areas, the Company is able to leverage an experienced workforce, robust infrastructure, and a long-standing tradition of excellence in sericulture.
Kraig Labs' multi-facility strategy is designed to support continuous production. By building redundancies directly into the production chain, the Company has created a stronger and more resilient foundation to meet the current demand and growing market for its recombinant spider silk materials.
"We are looking now for the site of an additional rearing center in order to further expand our production capacity," said Kim Thompson, Kraig Labs' founder and CEO. "We expect to lock in the site within the next 60 days. The goal is to further increase our capacity while building in resilience."
The addition of this new rearing center represents another milestone in Kraig Labs' expansion of its production capacity and its plans to bring the performance and sustainability benefits of recombinant spider silk to global markets.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
ir@KraigLabs.com
FAQ
What did Kraig Biocraft Laboratories (KBLB) announce on October 6, 2025?
How will the new KBLB rearing center affect production capacity?
When does KBLB expect to finalize the third facility location?
Where will Kraig Labs locate the new KBLB facility?
Does the announcement include financial details or timelines beyond site selection?
